Safety study of a new medicine in healthy volunteers
Part of Digestive system clinical trials.
This trial tests a new medicine called IN-114199 in healthy people to see if it is safe and how the body handles it. It is a first-in-human study, meaning it is the first time this drug is given to people.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy adult between the ages of 19 and 63.
- Your weight must be between 40 kg (about 88 lbs) and 100 kg (about 220 lbs), with a body mass index (BMI) between 18.5 and 29.9.
- You should not have any significant medical problems, such as heart, liver, kidney, or digestive diseases.
- You must not have taken certain medications that affect how your body processes drugs within the last month.
- You must be willing to avoid alcohol, caffeine, and smoking for a few days before and during the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new investigational drug called ID110521156 in healthy adults. The goal is to see if the drug is safe and how the body processes it. It may be for people who are overweight or obese.
This phase 1 trial tests a new medicine called IY-828026 in healthy volunteers to see how safe it is and how the body processes it. It's a first step to find the right dose and check for side effects.
This study tests two investigational drugs in healthy adults to see how the body absorbs, breaks down, and eliminates them, and to check for any side effects. If you are a healthy adult, you may be able to help researchers understand these drugs better.
This early-stage study tests a new investigational drug called HW201877 in healthy volunteers. The goal is to see if the drug is safe and how the body processes it.
This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.
This study tests a new investigational drug (called LMT503) for the first time in humans, in healthy volunteers. It is a phase 1 trial that will look at how the body processes the drug and its safety, including how it behaves in the blood. The trial involves taking the drug once (single dose) or multiple times over several days, with close monitoring by the research team.
Hear when a new Chronic Idiopathic Constipation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.